Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Nexgel Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NXGL
Nasdaq
2834
https://nexgel.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Nexgel Inc
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
- Apr 18th, 2024 12:00 pm
NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript
- Apr 2nd, 2024 2:42 pm
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
- Apr 1st, 2024 11:50 am
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
- Mar 27th, 2024 1:00 pm
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
- Mar 21st, 2024 1:00 pm
RETRANSMISSION: iAccess Alpha's Buyside Best Ideas Spring Virtual Conference March 12th and 13th, 2024
- Mar 11th, 2024 3:00 pm
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
- Mar 4th, 2024 1:30 pm
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
- Feb 21st, 2024 9:05 pm
NEXGEL to Present at The Microcap Conference, January 30th through February 1st
- Jan 18th, 2024 2:00 pm
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
- Jan 9th, 2024 1:30 pm
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
- Dec 11th, 2023 1:00 pm
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line
- Dec 5th, 2023 1:00 pm
NEXGEL, Inc. (NASDAQ:NXGL): When Will It Breakeven?
- Nov 26th, 2023 2:02 pm
NEXGEL, Inc. (NASDAQ:NXGL) Q3 2023 Earnings Call Transcript
- Nov 20th, 2023 3:00 pm
3 Stocks You’ll Regret Not Buying Soon: November 2023
- Nov 16th, 2023 11:35 am
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
- Nov 13th, 2023 9:05 pm
NEXGEL to Report Third Quarter 2023 Financial Results on November 13th
- Nov 2nd, 2023 1:00 pm
NEXGEL Secures Supply Agreement with AbbVie
- Oct 30th, 2023 12:00 pm
NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd
- Sep 26th, 2023 1:49 pm
Director Scott Henry Acquires 10,500 Shares of NexGel Inc
- Sep 15th, 2023 3:02 pm
Scroll